BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 38221591)

  • 1. Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
    Zeng L; Li Y; Hong C; Wang J; Zhu H; Li Q; Cui H; Ma P; Li R; He J; Zhu H; Liu L; Xiao L
    Osteoporos Int; 2024 Apr; 35(4):679-689. PubMed ID: 38221591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
    Zhang W; Li Y; Li S; Zhou J; Wang K; Li Z; Chen N; Chen X
    Front Endocrinol (Lausanne); 2023; 14():1278505. PubMed ID: 38116314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults.
    Li H; Luo H; Zhang Y; Liu L; Lin R
    Front Endocrinol (Lausanne); 2022; 13():891382. PubMed ID: 35846319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018.
    Liu J; Tang Y; Feng Z; Chen Y; Zhang X; Xia Y; Geng B
    Osteoporos Int; 2023 Apr; 34(4):713-724. PubMed ID: 36719471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mendelian-randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures.
    Pei X; Jiang W; Li L; Zeng Q; Liu CH; Wang M; Chen E; Zhou T; Tang H; Wu D
    J Gastroenterol Hepatol; 2024 May; 39(5):847-857. PubMed ID: 38240493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between alcohol intake and bone mineral density: results from the NHANES 2005-2020 and two-sample Mendelian randomization.
    Lai B; Jiang H; Gao R; Zhou X
    Arch Osteoporos; 2024 Mar; 19(1):21. PubMed ID: 38546895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between body circumference and testosterone levels and risk of metabolic dysfunction-associated fatty liver disease: a mendelian randomization study.
    Ning L; Sun J
    BMC Public Health; 2023 Mar; 23(1):602. PubMed ID: 36997893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Metabolism, Methylation Aberrant, and Osteoporosis: A Multi-omics Study Based on Mendelian Randomization.
    Zhang Z; Duan Y; Huo J
    Calcif Tissue Int; 2024 Feb; 114(2):147-156. PubMed ID: 38071623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.
    Huang Q; Guo J; Zhao H; Zheng Y; Zhang Y
    PLoS One; 2023; 18(10):e0292881. PubMed ID: 37856513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAFLD and Liver Fibrosis Are Not Associated With Reduced Femoral Bone Mineral Density in the General US Population.
    Ciardullo S; Muraca E; Zerbini F; Manzoni G; Perseghin G
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e2856-e2865. PubMed ID: 33878156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Non-Alcoholic Fatty Liver Disease and Degree of Hepatic Steatosis and Bone Mineral Density.
    Xie R; Liu M
    Front Endocrinol (Lausanne); 2022; 13():857110. PubMed ID: 35360054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetically predicted causal relationship of inflammatory bowel disease with bone mineral density and osteoporosis: evidence from two-sample Mendelian randomization.
    Xu D; Chen Y; Gao X; Xie W; Wang Y; Shen J; Yang G; Xie B
    Front Immunol; 2023; 14():1148107. PubMed ID: 37275908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lifestyle factors in mediating the effect of educational attainment on bone mineral density: a Mendelian randomization study.
    Liu Q; Tooki T; Di D; Zhou H; Cui Z; Zhang R; Zhang J; Yuan T; Zhou T; Luo X; Ling D; Wang Q
    Arch Osteoporos; 2023 Sep; 18(1):120. PubMed ID: 37723362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal effects of homocysteine levels on the changes of bone mineral density and risk for bone fracture: A two-sample mendelian randomization study.
    Wang P; Liu L; Lei SF
    Clin Nutr; 2021 Apr; 40(4):1588-1595. PubMed ID: 33744603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causal relationships between metabolic-associated fatty liver disease and iron status: Two-sample Mendelian randomization.
    He H; Liao S; Zeng Y; Liang L; Chen J; Tao C
    Liver Int; 2022 Dec; 42(12):2759-2768. PubMed ID: 36226474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between BMD and coronary artery calcification: an observational and Mendelian randomization study.
    Lu H; Lary CW; Hodonsky CJ; Peyser PA; Bos D; van der Laan SW; Miller CL; Rivadeneira F; Kiel DP; Kavousi M; Medina-Gomez C
    J Bone Miner Res; 2024 May; 39(4):443-452. PubMed ID: 38477752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Bone Mineral Density and Bone Turnover Markers with the Risk of Diabetes: Hong Kong Osteoporosis Study and Mendelian Randomization.
    Zhang X; Krishnamoorthy S; Tang CT; Hsu WW; Li GH; Sing CW; Tan KC; Cheung BM; Wong IC; Kung AW; Cheung CL
    J Bone Miner Res; 2023 Dec; 38(12):1782-1790. PubMed ID: 37850799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.
    Wu Z; Huang K; Bao S; Zhang X; Li J; Kong W; Shi Y; Xie Y
    Scand J Gastroenterol; 2024 May; 59(5):561-569. PubMed ID: 38235548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intervertebral Disk Degeneration and Bone Mineral Density: A Bidirectional Mendelian Randomization Study.
    Zhao J; Wang J; Xu H; Hu W; Shi F; Fan Z; Zhou C; Mu H
    Calcif Tissue Int; 2024 Mar; 114(3):228-236. PubMed ID: 37978069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Effect of Sodium-Glucose Cotransporter 2 Inhibition on Fracture Risk: Evidence From Mendelian Randomization and Genetic Association Study.
    Dai H; Zheng L; Zhu Z; Geng X; Hou T; Wang Q; Zhu Y; Lin H; Wang S; Zheng R; Zhao Z; Li M; Lu J; Xu Y; Wang T; Liu J; Ning G; Wang W; Bi Y; Zheng J; Xu M
    J Bone Miner Res; 2023 Nov; 38(11):1645-1653. PubMed ID: 37436694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.